Abstract:55 Pancreatic transplantation is an important therapeutic alternative for type I diabetic patients with renal failure. Since systemic immunosuppression is required to prevent acute rejection and maintain long-term graft function, the enthusiasm for pancreas transplantation to restore normoglycemia and prevent the complications in non-uremic diabetic patients is muted. Inhibition of the CD28/B7 pathway during T cell activation by CTLA4Ig produces a state of T cell anergy, resulting in prolonged graft survival and donor-specific tolerance. We hypothesized that local production of CTLA4Ig from the pancreas graft, achieved by adenoviral-mediated transfer of the CTLA4Ig gene to the graft ex vivo, may inhibit the immune responses against the pancreas and promote long-term graft survival. Methods: Pancreaticoduodenal grafts from Lewis donors were infected by AdlacZ or AdCTLA4Ig via arterial perfusion of 2.5×1010 virus, followed by 1.5-hour ex vivo incubation at 4°C. Grafts were washed with saline and transplanted into STZ-diabetic recipients (Lewis or W/F). Syngeneic AdlacZ-infected grafts were harvested at various time points after transplantation and LacZ expression was examined by X-gal staining. All animals with graft rejection were sacrificed at the time of rejection, and graft morphology examined histologically. To determine the local vs. the systemic effect of the locally delivered CTLA4Ig, co-transplantation of the transfected pancreas with non-transfected heart allografts were performed in two allogeneic strain combinations. Results: X-gal staining of pancreas isografts demonstrated lacZ gene expression in the endocrine and exocrine cells of the donor grafts beginning 1 day post-transplantation, reaching peak levels by day 3. LacZ expression was also observed in the recipient liver, however, by day 7 lacZ expression diminished in the liver, and virtually disappeared by day 14, though high levels of LacZ in the pancreas grafts were detected. AdCTLA4Ig toxicity was evaluated by syngeneic transplantation of virus-infected pancreases (n=4) and a survival time of greater than 100 days was achieved. Transplantation of control (non-treated, n=6) or AdlacZ-infected Lewis rat pancreases (n=4) into W/F recipients gave a mean survival time of 17 and 17.5 days, respectively. However, transplantation of AdCTLA4Ig-infected pancreas grafts (n=6) resulted in permanent survival of the graft (> 100 days). Subsequent transplantation of donor strain hearts (n=3) did not induce rejection, and long-term heart allograft survival was observed. Transplantation of third party (ACI) heart allografts (n=3) were rejected, though the survival time of the grafts was prolonged to a small degree vs. control (MST 22d vs. 7d, p<0.01). In the co-transplantation model, the non-transfected hearts (H) were rejected while the transfected pancreases (Pd) were accepted, confirming the effect of locally delivered CTLA4Ig. TableTableConclusion: This study demonstrates that arterial perfusion of the pancreas with adenovirus can lead to successful viral infection and gene transfer. Local expression of the CTLA4Ig gene can produce long-term graft survival and donor-specific tolerance in the rat pancreas transplant model. The immunosuppressive effect of CTLA4Ig protein appears limited to the transfected tissue rather than a systemic phenomenon.

The Effect of FasL Expression on Pancreatic Islet Allografts.

The Effect of FasL Gene Transfer to Islet Cells on Pancreatic Islet Allografts

The nole of Fas ligand positive testicular cells in systemic and local immunologic previlege for survival of co-transplanted islet cells

Cotransplantation of Allogeneic Islets and Testicular Cells Induces Immune Exemption for Islet Allografts in Rats

[Synergistic Protective Effect of Testicular Cells Expressing Fas Ligand and Cyclosporine A on the Survival of Islet Allografts].

Synergistic protective effect of testicular cells expressing Fas ligand and cyclosporine A on the survival of islet allografts

Sertoli Cell Induced Immune Privilege of Pancreatic Islet Allografts in Rat Intrahepatic

Changes in the Expression of Fas on T Lymphocytes after Allogeneic Fetal Thymus Transplantation in Systemic Lupus Erytematosus Mice.

[Co-Transplantation of Islet and Allogeneic Testicular Cell Induced Immune Privilege].

IMPROVED SURVIVAL OF BIOLISTICALLY TRANSFECTED MOUSE ISLET ALLOGRAFTS EXPRESSING CTLA4-Ig OR SOLUBLE FAS LIGAND1

LOCAL EXPRESSION OF RECOMBINANT CTLA4IG GENE IN THE PANCREAS INDUCES PERMANENT PANCREAS GRAFT SURVIVAL AND DONOR-SPECIFIC TOLERANCE:

Long-Term Immunological and Functional Effects of Adenoviral-Mediated Ctla4-Ig Gene Transfer into Pancreatic Allografts

Utility of adenovirus-mediated Fas ligand and bcl-2 gene transfer to modulate rat liver allograft survival.

Induction of lymphocyte apoptosis in rat liver allograft by adenoviral gene transfection of human interleukin-10.

Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice

Transfusion of Endothelial Cells with Lentivirus-Mediated Expression of Fas Ligand Prolonged Survival of Rat Liver Allograft

Allogenic porcine transplantation of FasL+ -transfected tissue engineered chondrocytes

Intercellular Adhesion Molecular-1, Fas, and Fas Ligand as Diagnostic Biomarkers for Acute Allograft Rejection of Pancreaticoduodenal Transplantation in Pigs

Adenovirus-mediated CTLA4-Ig and FasL Gene Transfer Induces Long-Term Survival of Renal Allografts in Rats

[Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts].

Fas Ligand Gene Transfer Combined with Low Dose Cyclosporine A Reduces Acute Lung Allograft Rejection.